L. Calo et al., Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome - Relationship to vascular reactivity, CLIN NEPHR, 51(1), 1999, pp. 12-17
Aim: Patients with Bartter's syndrome and Gitelman's syndrome have reduced
vascular reactivity, normo-hypotension and decreased peripheral resistances
in spite of biochemical and hormonal abnormalities typical of hypertension
. Since we found that both types of patients have increased urinary NO2-/NO
3-, metabolites of NO, that correlated with their increased urinary cGMP, s
econd messenger of NO, we examined the possible role of NO system in the pa
thophysiology of these syndromes. Patients and methods: We used a molecular
biologic approach and studied ecNOS gene expression by PCR-amplification o
f cDNA obtained by RT-PCR of RNA extracted by patients and healthy controls
monocytes. Results: echNOS is overexpressed in monocytes from patients wit
h Bartter's and Gitelman's syndrome relative to controls: - 0.306 +/- 0.012
Densitometric Units (0.313 +/- 0.006, N = 3 for Bartter's patients; 0.302
+/- 0.009, N = 5 for Gitelman's patients) vs. 0.192 +/- 0.018, p < 0.0001.
Conclusion: This overexperession presumably accounts for their increased NO
production; thus it could be likely that elevated ecNOS and NO levels are
a part of pathophysiological process(es) that leads to their characteristic
reduced vascular responses. However, the relationship between the alterati
ons in the NO signalling system observed in this study and the mutations in
either Na+-K+-2Cl cotransporter or in a K+ channel ROMK or in Cl-channel C
lCNKB in Bartter's syndrome and in Na+-Cl- cotranstransporter in Gitelman's
syndrome, recently reported as their primary defects remains to be defined
.